Genetic variations in multiple myeloma II: association with effect of treatment.
about
Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision MedicineInherited genetic susceptibility to multiple myeloma.The role of P-glycoprotein in drug resistance in multiple myeloma.Not too little, not too much-just right! (Better ways to give high dose melphalan).A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma.Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors.Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma.The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma.Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.A Novel Green Synthesis of Thalidomide and Analogs
P2860
Q26799238-7A778900-7307-415E-923C-FC22ED02455EQ38163845-692E59D0-189C-45ED-B75B-DD3CC4360FA3Q38200143-263234A8-D620-4B26-92C0-BE6480FFFFB8Q38240941-AD107475-6C61-4FAA-8087-01CA7C3455BCQ38700339-05E6FA03-E0EC-451A-AE54-2643828068EBQ38808490-3DAACA7F-2A2F-474C-B39F-558C7F7AF09DQ40286050-88C5D7E2-7D26-4E69-8EE2-7EC13B57244EQ42132693-52AFFF54-48E8-4978-978D-5B887AE3C762Q48153195-0FCE4576-B589-4921-AD8B-D07092000D23Q48234027-BA39FC68-5624-4AF2-ACA3-6EA6976D8300Q50588462-DFD38317-6804-463B-86FF-5CAF9CAB4ED0Q53185874-CC52B3E0-C69B-46EF-8B18-B9EC3D722264Q59145948-EDDAB6A4-058C-4435-AF4F-CC78275656DC
P2860
Genetic variations in multiple myeloma II: association with effect of treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Genetic variations in multiple myeloma II: association with effect of treatment.
@en
Genetic variations in multiple myeloma II: association with effect of treatment.
@nl
type
label
Genetic variations in multiple myeloma II: association with effect of treatment.
@en
Genetic variations in multiple myeloma II: association with effect of treatment.
@nl
prefLabel
Genetic variations in multiple myeloma II: association with effect of treatment.
@en
Genetic variations in multiple myeloma II: association with effect of treatment.
@nl
P2860
P1476
Genetic variations in multiple myeloma II: association with effect of treatment.
@en
P2093
Tobias W Klausen
P2860
P304
P356
10.1111/J.1600-0609.2011.01696.X
P577
2011-11-16T00:00:00Z